Suraj Kalia
Stock Analyst at Oppenheimer
(3.54)
# 697
Out of 5,182 analysts
94
Total ratings
44.3%
Success rate
8.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Perform | n/a | $44.26 | - | 4 | May 7, 2026 | |
| PODD Insulet | Maintains: Outperform | $300 → $210 | $154.16 | +36.22% | 2 | May 7, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $132 → $115 | $84.32 | +36.39% | 3 | Apr 17, 2026 | |
| PRCT PROCEPT BioRobotics | Downgrades: Perform | n/a | $25.40 | - | 3 | Feb 26, 2026 | |
| TMDX TransMedics Group | Maintains: Outperform | $150 → $175 | $67.84 | +157.96% | 12 | Feb 25, 2026 | |
| ATRC AtriCure | Downgrades: Perform | n/a | $26.28 | - | 8 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $125 → $100 | $53.93 | +85.43% | 1 | Jan 16, 2026 | |
| VREX Varex Imaging | Maintains: Outperform | $23 → $18 | $9.83 | +83.11% | 7 | Nov 19, 2025 | |
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $79.96 | - | 6 | Oct 8, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $19.08 | +15.30% | 1 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $120 | $120.66 | -0.55% | 7 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $32 | $25.41 | +25.93% | 3 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $90 → $93 | $107.94 | -13.84% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $4.43 | +125.73% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $3.22 | +304.35% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $88.12 | +53.20% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $206.76 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $25.65 | +16.96% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $0.51 | +38,886.35% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $63.47 | +52.83% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.08 | +26.84% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $4.16 | +8.17% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.06 | +1,409.43% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $450.06 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $1.73 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $17.99 | +455.86% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $60.61 | - | 5 | Sep 12, 2018 |
Inspire Medical Systems
May 7, 2026
Maintains: Perform
Price Target: n/a
Current: $44.26
Upside: -
Insulet
May 7, 2026
Maintains: Outperform
Price Target: $300 → $210
Current: $154.16
Upside: +36.22%
Abbott Laboratories
Apr 17, 2026
Maintains: Outperform
Price Target: $132 → $115
Current: $84.32
Upside: +36.39%
PROCEPT BioRobotics
Feb 26, 2026
Downgrades: Perform
Price Target: n/a
Current: $25.40
Upside: -
TransMedics Group
Feb 25, 2026
Maintains: Outperform
Price Target: $150 → $175
Current: $67.84
Upside: +157.96%
AtriCure
Feb 18, 2026
Downgrades: Perform
Price Target: n/a
Current: $26.28
Upside: -
Boston Scientific
Jan 16, 2026
Maintains: Outperform
Price Target: $125 → $100
Current: $53.93
Upside: +85.43%
Varex Imaging
Nov 19, 2025
Maintains: Outperform
Price Target: $23 → $18
Current: $9.83
Upside: +83.11%
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $79.96
Upside: -
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $19.08
Upside: +15.30%
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $120.66
Upside: -0.55%
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $25.41
Upside: +25.93%
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $107.94
Upside: -13.84%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.43
Upside: +125.73%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $3.22
Upside: +304.35%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $88.12
Upside: +53.20%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $206.76
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $25.65
Upside: +16.96%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $0.51
Upside: +38,886.35%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $63.47
Upside: +52.83%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $22.08
Upside: +26.84%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $4.16
Upside: +8.17%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.06
Upside: +1,409.43%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $450.06
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $1.73
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $17.99
Upside: +455.86%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $60.61
Upside: -